Eli Lilly Muted As Arthritis Drug Fails Goals In Covid-19 Patients

© Reuters By Dhirendra Tripathi Investing.com – Shares of Eli Lilly (NYSE:) were marginally negative as the company’s announcement that the phase 3 study of a drug for treating rheumatoid arthritis in Covid-19 patients had failed to meet its goals left traders disappointed. Eli’s filing said patients treated with baricitinib were 2.7% less likely than […]

Continue Reading

AirBnB Frenzy, FDA to Approve Pfizer Drug, No-Deal Brexit – What’s up in Markets

© Reuters. By Geoffrey Smith  Investing.com — AirBnB stokes the biggest IPO frenzy in 20 years, the FDA prepares to approve Pfizer’s Covid-19 drug and the EU and U.K. are heading for a messy divorce. Plus, stimulus talks appear close to breakdown despite surge in jobless claims. Here’s what you need to know in financial  markets […]

Continue Reading

The UK is moving to get Oxford-Astra COVID-19 vaccine drug approved faster

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment; do […]

Continue Reading

India gives Hetero Labs approval to make Gilead’s COVID-19 drug

© Reuters. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19), in California (Reuters) – India’s drug regulator has given Hetero Labs the green light to manufacture and market its generic version of Gilead Science’s experimental COVID-19 treatment remdesivir, the Indian pharmaceutical company said on Sunday. The […]

Continue Reading

Asian stocks set to rise as drug trials, data push Wall Street higher

By Katanga Johnson WASHINGTON (Reuters) – Asian stocks were set to climb on Wednesday after another late Wall Street surge in response to upbeat trial results for a COVID-19 treatment and data showing U.S. consumers spent big in May. The prospects of fresh support from the Federal Reserve and Bank of Japan also supported global […]

Continue Reading

Global stocks fall on worries over EU stimulus details, coronavirus drug

2/2 © Reuters. Pedestrian wearing a face mask walks near an overpass with an electronic board showing stock information in Shanghai 2/2 By Tom Arnold LONDON (Reuters) – Global shares fell on Friday, hit by delays to an agreement on divisive details of the European Union’s stimulus package and doubts about progress in the development […]

Continue Reading